Broad-spectrum antiviral activity of 3D8, a nucleic acid-hydrolyzing single chain variable fragment (scFv), targeting SARS-CoV-2 and multiple coronaviruses in vitro

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

Background

The current pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the etiology of Coronavirus-induced disease 19 (COVID-19) and poses a critical public health threat worldwide. Effective therapeutics and vaccines against multiple coronaviruses remain unavailable. Single chain variable fragment (scFv), a recombinant antibody exhibits broad-spectrum antiviral activity against DNA and RNA viruses owing to its nucleic acid-hydrolyzing property.

Objective

This study is aimed to investigate an antiviral activity of 3D8 scFv against SARS-CoV-2 and other coronaviruses.

Methods

3D8, a recombinant scFv antibody was evaluated for antiviral activity against SARS-CoV-2, HCoV-OC43 and PEDV in Vero E6 cell cultures. Viral growth was quantified with quantitative RT-qPCR and plaque assay. Nucleic acid hydrolyzing activity of 3D8 was assessed through abzyme assays of in vitro viral transcripts and cell viability was determined by MTT assay.

Results

3D8 inhibited the replication of SARS-CoV-2, human coronavirus OC43 (HCoV-OC43), and porcine epidemic diarrhea virus (PEDV). Our results revealed the prophylactic and therapeutic effects of 3D8 scFv against SARS-CoV-2 in Vero E6 cells. Immunoblot and plaque assays showed the reduction of coronavirus nucleoproteins and infectious particles respectively in 3D8 scFv-treated cells.

Conclusions

This data demonstrates the broad-spectrum antiviral activity of 3D8 against SARS-CoV-2 and other coronaviruses. Thus, it could be considered a potential antiviral countermeasure against SARS-CoV-2 and zoonotic coronaviruses.

Article activity feed

  1. SciScore for 10.1101/2020.11.25.398909: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    After transmembrane transfer, it was incubated with primary antibodies; anti-SARS-CoV-2 (PA1-41098, Invitrogen, Thermo Fisher Scientific, Massachusetts, USA)
    anti-SARS-CoV-2 ( PA1-41098
    suggested: None
    , anti-PEDV (9191, Median Diagnostics, Chuncheon-si, ROK), anti-HCoV-OC43(LS-C79764, LS-bio, Seattle, WA, USA) and anti-human GAPDH antibody (ab9485, Abcam, Cambridge, UK) overnight at 4°C and then incubated with anti-mouse or rabbit IgG-HRP conjugate (209-035-082 or 309-035-003, Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at 37 °C.
    anti-PEDV
    suggested: None
    anti-human GAPDH
    suggested: None
    anti-mouse
    suggested: None
    rabbit IgG-HRP
    suggested: None
    After blocking with 1% BSA and 0.3 M (22.52 mg/ml) glycine in PBST buffer for 1 h at room temperature, primary antibodies for detecting PEDV (mouse anti-PEDV monoclonal Ab, MBS313516, Mybio), HCoV-OC43 (mouse anti-OC43 monoclonal Ab, LS-C79764, LS-bio) and 3D8 (polyclonal rabbit IgG serum Ab) were incubated overnight at 4 °C.
    HCoV-OC43
    suggested: None
    anti-OC43
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    Cells and viruses: African green monkey kidney epithelial Vero cells (ATCC® CCL-81) and Vero E6 cells (ATCC® CRL-1586) were maintained in Dulbecco’s modified Eagle’s medium (12-604F, Lonza, BioWhittaker®, Walkersville, MD, USA) supplemented with 10% Fetal bovine serum (FBS, Gibco, Life Technologies, Grand Island, NY, USA), 1% 10 mM HEPES in 0.85% NaCl (17-737E, Lonza, BioWhittaker®, Walkersville, MD, USA) and 100 U/ml Penicillin-100 µg/ml Streptomycin (15140-122, Gibco, Life Technologies, Grand Island, NY, USA)
    Vero
    suggested: ATCC Cat# CRL-1586, RRID:CVCL_0574)
    In case of prophylactic treatment, Vero E6 cells were treated with 3D8 and incubated overnight before the virus challenge.
    Vero E6
    suggested: None
    Software and Algorithms
    SentencesResources
    Viral RNA was quantified using Power SYBR® Green PCR Master Mix (4367659, Applied Biosystems™, Life Technologies Ltd., Woolston
    Applied Biosystems™
    suggested: (Applied Biosystems, RRID:SCR_005039)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    However, the absence of in vivo studies in animal models is a major limitation. To address this issue, further studies are needed to illustrate the in vivo inhibitory effect of 3D8 scFv in transgenic mice, Syrian hamsters and non-human primate models. In conclusion, 3D8 scFv confers broad-spectrum antiviral activity against SARS-CoV-2 and multiple coronaviruses. This study provides insights into the effective antiviral countermeasure of scFv against emerging viral outbreaks.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.